We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Roche, Wells Fargo, General Electric, Microsoft and Intuit
Read MoreHide Full Article
For Immediate Release
Chicago, IL – December 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Roche Holding AG (RHHBY - Free Report) , Wells Fargo & Company (WFC - Free Report) , General Electric Company (GE - Free Report) , Microsoft Corporation (MSFT - Free Report) and Intuit Inc. (INTU - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Stock Reports for Roche, Wells Fargo and General Electric
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Roche Holding, Wells Fargo and General Electric. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Roche have gained +12.6% over the past year against the Zacks Large Cap Pharmaceuticals industry’s increase of +7.8%. While the company’s sales in the first quarter were strong, the metric declined in the second quarter and again stabilized somewhat in the third. The Zacks analyst believes that although growth in Ocrevus, Perjeta, Tecentriq and Hemlibra maintained momentum, COVID-19 disruptions and biosimilar competition for Herceptin, MabThera and Avastin weighed on the solid performances.
Nevertheless, the Diagnostics division was boosted by the launch of diagnostic products for COVID-19 and should sustain this uptrend in the next few quarters. Label expansion of Tecentriq into additional indications is a positive and should surge sales.
Wells Fargo shares have underperformed the Zacks Banks - Major Regional industry in the year to date period (-46.0% vs. -21.3%). The Zacks analyst believes that Wells Fargo's revenues remain under pressure due to low interest rates and a volatile fee income trend. Also, rising expenses in providing benefits to clients amid coronavirus concerns might curb bottom-line growth. Legal hassles also remain a concern.
Nevertheless, the company's efforts to enhance compliance and risk-management capability, along with streamlining activities seem encouraging. Also, strong loans and deposits balance depicts robust capital position. Moreover, given a strong liquidity position, the company carries less credit risk in case of any economic downturn. Improving credit quality remains a tailwind.
General Electric shares have outperformed the Zacks Diversified Operations industry over the past three-month period (+91.4% vs. +23.3%). The Zacks analyst believes that the company is poised to gain from its portfolio-restructuring program, expansion in digital business, efforts to deleverage balance sheet and solid liquidity position in the quarters ahead.
However, the pandemic-related market challenges — especially for Healthcare, Aviation and Power — related to the pandemic remain concerning. Its measures to deal with the pandemic might be a relief. In addition, forex woes might hurt in the quarters ahead.
Other noteworthy reports we are featuring today include Microsoft and Intuit.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year. These 7 were selected because of their superior potential for immediate breakout.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Roche, Wells Fargo, General Electric, Microsoft and Intuit
For Immediate Release
Chicago, IL – December 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Roche Holding AG (RHHBY - Free Report) , Wells Fargo & Company (WFC - Free Report) , General Electric Company (GE - Free Report) , Microsoft Corporation (MSFT - Free Report) and Intuit Inc. (INTU - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Stock Reports for Roche, Wells Fargo and General Electric
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Roche Holding, Wells Fargo and General Electric. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Roche have gained +12.6% over the past year against the Zacks Large Cap Pharmaceuticals industry’s increase of +7.8%. While the company’s sales in the first quarter were strong, the metric declined in the second quarter and again stabilized somewhat in the third. The Zacks analyst believes that although growth in Ocrevus, Perjeta, Tecentriq and Hemlibra maintained momentum, COVID-19 disruptions and biosimilar competition for Herceptin, MabThera and Avastin weighed on the solid performances.
Nevertheless, the Diagnostics division was boosted by the launch of diagnostic products for COVID-19 and should sustain this uptrend in the next few quarters. Label expansion of Tecentriq into additional indications is a positive and should surge sales.
(You can read the full research report on Roche here >>>)
Wells Fargo shares have underperformed the Zacks Banks - Major Regional industry in the year to date period (-46.0% vs. -21.3%). The Zacks analyst believes that Wells Fargo's revenues remain under pressure due to low interest rates and a volatile fee income trend. Also, rising expenses in providing benefits to clients amid coronavirus concerns might curb bottom-line growth. Legal hassles also remain a concern.
Nevertheless, the company's efforts to enhance compliance and risk-management capability, along with streamlining activities seem encouraging. Also, strong loans and deposits balance depicts robust capital position. Moreover, given a strong liquidity position, the company carries less credit risk in case of any economic downturn. Improving credit quality remains a tailwind.
(You can read the full research report on Wells Fargo here >>>)
General Electric shares have outperformed the Zacks Diversified Operations industry over the past three-month period (+91.4% vs. +23.3%). The Zacks analyst believes that the company is poised to gain from its portfolio-restructuring program, expansion in digital business, efforts to deleverage balance sheet and solid liquidity position in the quarters ahead.
However, the pandemic-related market challenges — especially for Healthcare, Aviation and Power — related to the pandemic remain concerning. Its measures to deal with the pandemic might be a relief. In addition, forex woes might hurt in the quarters ahead.
(You can read the full research report on General Electric here >>>)
Other noteworthy reports we are featuring today include Microsoft and Intuit.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.